Given these rapid advances and some confusion created by the marketing terminology such as calling event recorders 'mini-Holter', it is worth reviewing the core features of event recorders and the utility of the additional features. Cardiac event recorders allow the capture of surface electrogram at the time of cardiac events, typically during suspected cardiac arrhythmias. Less frequently they are employed to detect ST segment change, to monitor cardiac rhythm and detect assymptomatic arrhythmias in pharmacotherapy trials, or to detect the recurrence of atrial~brillation. The duration of recordings varies, but is typically in the range of 1 to 5 minutes. Event recorders can be nonlooping devices, that are applied to the skin only at the time of symptoms (or at pre-arranged intervals for the other applications mentioned). With looping event recorders, skin electrodes are worn continuously for 1 to 4 weeks. The device stores 30 seconds to 5 minutes of preceding electrogram in a loop that is continuously overwritten. When the event button is pressed the loop is permanently stored and the device prospectively acquires a further period of ECG. Most systems offer a facility for trans-telephonic transfer of the recording, the utility of which is dependant upon the clinical purpose of the recording. To determine the cardiac rhythm during symptoms only a single recording is required, as long as the activation was timed to capture the correct period of ECG and the symptoms were typical of the patient's clinical episodes. In this setting it is preferable to ask the patient to attend for on-site downloading of the ECG as, if the correct ECG was not stored, the patient probably requires further instruction on using the device. However for serial recording, the facility for transtelephonic transfer is invaluable. The requirement to send as an analogue audio signal has an inevitable deleterious effect on signal quality and frequency content, but does not usually degrade the signal to a degree suf~cient to hindering interpretation. Newer devices offer improved transmission speeds and transmission via the internet will probably come to the fore in future. It is already offered by at least one company (Cardiac Evaluation Center, Inc., Milwaukee, WI).
Most recorders now use specialised software loaded onto a standard PC type computer rather than having a dedicated reporting station. The signal is transferred to the computer either transtelephonically, via the computer's serial port, or by removing the PCMIA memory card from the recorder and inserting it into a slot of the PC. Patient details are entered and stored in a proprietary database, as are electrograms, allowing archiving to computer tape or to recordable CD-ROM, if desired. Automated rhythm analysis is not usually offered, being super_uous given the short duration of individual strips. However the facility to perform on-screen caliper measurement of cardiac intervals is desirable.
Patient Activation vs. Automated Triggering
Most event recorder type devices require patient activation to trigger a recording, which is both an advantage and a potential limitation. Patient activation en-sures that detected tachy-or brady-arrhythmias correspond to the patient symptoms. This avoids the dif~culty in determining the clinical relevance of some Holter detected arrhythmias, such as the differing views regarding the signi~cance of asymptomatic ventricular pauses [2, 3] . The requirement for patient activation, however, can cause signi~cant practical dif~cul-ties. With looping devices, the record button may be pressed inadvertently when worn on a belt. With any type of event recorder the patient can forget how to activate the device correctly given the time lag between patient instruction and device use, particularly if multiple key press combinations or several buttons exist. Finally the patient may not properly report or may forget the timing of activation of the device in relation to the clinical event. If no arrhythmia is seen, the question arises of whether there was no signi~cant arrhythmia or if the recording simply not performed at the correct time.
Automated triggering on cardiac arrhythmias requires very accurate recognition of ventricular events, as relatively minor over-or under-detection of ventricular events would results in an unacceptable amount of 'false positive' device recordings. However the facility is offered by at least two currently available systems. In order to maximise the accuracy of on-board ventricular signal recognition, neural net systems have been developed. The 'C.Net2000' (Cardionetics Ltd., U.K.) analyses the acquired ECG in real time and representative segments of arrhythmia are stored. A report is provided of the timing and nature of arrhythmia events without requiring any editing. The device is currently marketed as a screening device to allow primary care physicians the ability to evaluate minor symptoms and avoid unnecessary referrals.
Quality of Acquired ECG and Multichannel Recordings
Early event recorders offered only single channel ECG, but a minimum of two channels are now generally provided. Looping event recorders that utilise chest electrodes (a wrist worn looping event recorder is marketed) have the advantage of acquiring a 'conventional' bipolar signal such as ECG lead II or a bipolar V5 lead. In contrast, the physician has less control over the positioning or orientation of a device that is applied by the patient to make a recording, and the bipole is shorter (reducing the amplitude of the acquired ECG). In order to minimize the number of ECG leads required, some devices alternate the sampled channels, allowing referencing to the unsampled lead, and reducing the number of leads needed for two channel recording from 5 to 4 or 3.
Full 12 lead ECG for trans-telephonic transmission can be achieved with recorders such as the Heartview P-12/8 (Aerotel Medical Systems Ltd, Israel), which uses three adhesive electrode leads and records the precordial channels via metal electrodes on the rear of the recorder sequentially positioned at C1/C2, C3/C4 and~nally at C5/C6. Currently the device does not offer loop recording of the three permanently applied electrodes, and it is best suited to remote monitoring and evaluation of sustained symptoms where a full 12 lead ECG is desirable.
Looping event recording of 12 lead ECG is constrained by the practically of wearing the 10 electrodes required for many days. To overcome this, electrodes and the initial lead can be incorporated into manufactured adhesive strips, reducing the number of separate electrodes and length of cables needed. Alternatively, the full 12 lead ECG can be reconstructed from limited channels by digital signal processing techniques [4] .
Diagnostic Yield and Cost Ef~cacy
Looping event recorders are the optimal recording technology to use to detect the cardiac arrhythmia underlying patient symptoms in most situations. An exception is events that occur once or more a day, which may reasonably be expected to be detected with conventional Holter technology. Equally, where events are very infrequent, an implantanle loop recorder or invasive electrophysiological testing may be a more suc- CEPR 1999; Vol. 3, No. 4 Cardiac ECG Event Recorders 
